Covered recipient · General Payments record
ROSS M CAMPBELL
Allopathic & Osteopathic Physicians Dermatology MOHS-Micrographic Surgery
General Payments · PY2018–2024
$3,435.09
- Reported across 187 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $571.73 | 24 |
| Education | $145.04 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $258.75 | 21 |
| Galderma Laboratories, L.P. | $109.09 | 2 |
| Janssen Biotech, Inc. | $108.99 | 2 |
| GENZYME CORPORATION | $79.53 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $56.59 | 2 |
| UCB, Inc. | $27.59 | 1 |
| Regeneron Healthcare Solutions, Inc. | $21.44 | 1 |
| LEO Pharma Inc. | $20.36 | 1 |
| Lilly USA, LLC | $18.79 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $15.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.23 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410161 | CMS |
| ABBVIE INC. | $8.45 | 02/01/2024 | Education | Undisputed | 01/23/2026 | 1104194690 | CMS |
| ABBVIE INC. | $8.45 | 02/01/2024 | Education | Undisputed | 01/23/2026 | 1104194692 | CMS |
| ABBVIE INC. | $8.45 | 02/01/2024 | Education | Undisputed | 01/23/2026 | 1104194694 | CMS |
| ABBVIE INC. | $8.45 | 02/01/2024 | Education | Undisputed | 01/23/2026 | 1104194696 | CMS |
| ABBVIE INC. | $8.45 | 02/01/2024 | Education | Undisputed | 01/23/2026 | 1104194698 | CMS |
| ABBVIE INC. | $8.45 | 02/01/2024 | Education | Undisputed | 01/23/2026 | 1104194700 | CMS |
| ABBVIE INC. | $8.45 | 02/01/2024 | Education | Undisputed | 01/23/2026 | 1104194702 | CMS |
| ABBVIE INC. | $8.45 | 02/01/2024 | Education | Undisputed | 01/23/2026 | 1104194704 | CMS |
| ABBVIE INC. | $8.45 | 02/01/2024 | Education | Undisputed | 01/23/2026 | 1104194706 | CMS |
| ABBVIE INC. | $17.68 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410163 | CMS |
| ABBVIE INC. | $4.62 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410165 | CMS |
| ABBVIE INC. | $26.00 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410167 | CMS |
| ABBVIE INC. | $19.73 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410169 | CMS |
| ABBVIE INC. | $14.87 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410171 | CMS |
| ABBVIE INC. | $20.61 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410173 | CMS |
| ABBVIE INC. | $2.53 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410175 | CMS |
| ABBVIE INC. | $23.55 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410177 | CMS |
| ABBVIE INC. | $18.92 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410179 | CMS |
| ABBVIE INC. | $15.20 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410181 | CMS |
| ABBVIE INC. | $7.76 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410183 | CMS |
| Galderma Laboratories, L.P. | $14.21 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145288900 | CMS |
| Galderma Laboratories, L.P. | $94.88 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145288902 | CMS |
| GENZYME CORPORATION | $44.73 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139763564 | CMS |
| GENZYME CORPORATION | $34.80 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139763582 | CMS |
| Janssen Biotech, Inc. | $40.00 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078558204 | CMS |
| Janssen Biotech, Inc. | $68.99 | 07/08/2024 | Education | Undisputed | 01/23/2026 | 1078558346 | CMS |
| LEO Pharma Inc. | $20.36 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152622615 | CMS |
| Lilly USA, LLC | $18.79 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135380641 | CMS |
| Novartis Pharmaceuticals Corporation | $26.40 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086724549 | CMS |
| Novartis Pharmaceuticals Corporation | $30.19 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086724557 | CMS |
| Regeneron Healthcare Solutions, Inc. | $21.44 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114018563 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $15.64 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152197469 | CMS |
| UCB, Inc. | $27.59 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143399612 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.